Cytomegalovirus Pulmonary Involvement in an Immunocompetent Adult

Table 1

Analytical evolution from the 1^st visit to ER up to 8 days of therapy with valganciclovir.

	1^st trip to ER	2^nd trip to ER	2^nd day of hospitalization	9^th day of hospitalization	13^th day of hospitalization	8^th day on valganciclovir
Hemoglobin (g/dL)	11.1	9.7	8.9	8.9	11,5	12
VCM (fL)	86.4	88.3	88.3	90.3	91,1	90,4
HCM (pg)	29.8	30.1	29.3	29.5	29,4	31,2
Prothrombin time (seg)	17.6	15.8	15.4	—	14,3	12,7
INR (ratio)	1.5	1.3	1.3	—	1,2	1,1
ALT/GPT (U/L)	199	153	249.9	190.6	120,4	68,8
AST/GOT (U/L)	207	95.9	192.2	79	56,4	35,4
GGT (U/L)	—	—	197.3	381.8	291,2	164,0
LDH (U/L)	692.0	749.0	885.	792	631,0	323,0
TBIL (mg/dL)	—	0.9	0.8	0.7	0,7	0.5
ALP (U/L)	—	—	106.	143	121,0	105,0
CRP (mg/L)	22.3	46.5	55.4	26	6,8	—
Anti-CMV IgG (UA/mL)	—	—	21.4	—	75,7	71,3
Anti-CMV IgM (S/CO)	—	—	6.9	—	9,0	6,5
DNA (PCR) – cytomegalovirus (copies/mL)	—	—	91880	—	<250	<250